Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H19NO6 |
Molecular Weight | 417.4108 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC1=CC=C(C=C1)C2(OC3=CC=CC=C3NC2=O)C4=CC=C(OC(C)=O)C=C4
InChI
InChIKey=ZCBJDQBSLZREAA-UHFFFAOYSA-N
InChI=1S/C24H19NO6/c1-15(26)29-19-11-7-17(8-12-19)24(18-9-13-20(14-10-18)30-16(2)27)23(28)25-21-5-3-4-6-22(21)31-24/h3-14H,1-2H3,(H,25,28)
DescriptionSources: http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/205764/1/ngh033006_1122.pdfCurator's Comment: description was created based on several sources, including
http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE022924&leafletType=leafletFR
Sources: http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/205764/1/ngh033006_1122.pdf
Curator's Comment: description was created based on several sources, including
http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE022924&leafletType=leafletFR
Bisoxatin (Laxonalin, Wylaxine) acetate is a stimulant laxative that has been used in the treatment of constipation. The drug showed good effects to habitual constipation and dolichocolon but was not sufficient acting in megacolon. It seems that the drug is effective to constipation due to functional disorders but the effect is not sufficient to constipation caused chiefly by organic colonic changes. No side effect was observed even in long term administration.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29797
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB14654
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
DTXSID1048839
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
237-820-5
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
26391
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106004
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
79W5LFS83K
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
m2566
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000085120
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
C030065
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
14008-48-1
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
C142961
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
SUB00833MIG
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
382
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD